Movatterモバイル変換


[0]ホーム

URL:


AU2003218063A1 - Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist - Google Patents

Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist

Info

Publication number
AU2003218063A1
AU2003218063A1AU2003218063AAU2003218063AAU2003218063A1AU 2003218063 A1AU2003218063 A1AU 2003218063A1AU 2003218063 AAU2003218063 AAU 2003218063AAU 2003218063 AAU2003218063 AAU 2003218063AAU 2003218063 A1AU2003218063 A1AU 2003218063A1
Authority
AU
Australia
Prior art keywords
mglu2
psychoses
therapy
combining
receptor agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003218063A
Inventor
Bryan Glenn Johnson
Darryle Darwin Schoepp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and CofiledCriticalEli Lilly and Co
Publication of AU2003218063A1publicationCriticalpatent/AU2003218063A1/en
Abandonedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

AU2003218063A2002-04-032003-03-21Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonistAbandonedAU2003218063A1 (en)

Applications Claiming Priority (5)

Application NumberPriority DateFiling DateTitle
US36977102P2002-04-032002-04-03
US36979702P2002-04-032002-04-03
US60/369,7972002-04-03
US60/369,7712002-04-03
PCT/US2003/007283WO2003084610A1 (en)2002-04-032003-03-21Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist

Publications (1)

Publication NumberPublication Date
AU2003218063A1true AU2003218063A1 (en)2003-10-20

Family

ID=28794376

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AU2003218063AAbandonedAU2003218063A1 (en)2002-04-032003-03-21Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist

Country Status (5)

CountryLink
EP (1)EP1492595A1 (en)
JP (1)JP2005528378A (en)
AU (1)AU2003218063A1 (en)
CA (1)CA2478227A1 (en)
WO (1)WO2003084610A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CA2488167C (en)2002-06-112012-07-24Eli Lilly And CompanyProdrugs of excitatory amino acids
AU2008200612B8 (en)*2002-06-112011-03-10Eli Lilly And CompanyProdrugs of excitatory amino acids
TWI417095B (en)2006-03-152013-12-01Janssen Pharmaceuticals Inc1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
TW200845978A (en)2007-03-072008-12-01Janssen Pharmaceutica Nv3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en)2007-03-072009-01-01Janssen Pharmaceutica Nv3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
WO2009033704A1 (en)2007-09-142009-03-19Ortho-Mcneil-Janssen Pharmaceuticals, Inc.1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1, 4'] bipyridinyl-2'-ones
CA2735764C (en)2008-09-022016-06-14Ortho-Mcneil-Janssen Pharmaceuticals, Inc.3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
WO2010060589A1 (en)2008-11-282010-06-03Ortho-Mcneil-Janssen Pharmaceuticals, Inc.Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
EA020671B1 (en)2009-05-122014-12-30Янссен Фармасьютикалз, Инк.1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF mGluR2 RECEPTORS
SG176021A1 (en)2009-05-122011-12-29Janssen Pharmaceuticals Inc1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
MY153913A (en)2009-05-122015-04-15Janssen Pharmaceuticals Inc7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
ES2552879T3 (en)2010-11-082015-12-02Janssen Pharmaceuticals, Inc. 1,2,4-Triazolo [4,3-a] pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
EP2643320B1 (en)2010-11-082015-03-04Janssen Pharmaceuticals, Inc.1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
US9271967B2 (en)2010-11-082016-03-01Janssen Pharmaceuticals, Inc.1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
BR112013031928B1 (en)2011-06-172022-05-24Eli Lilly And Company Bicyclo (3.1.0) hexane-2,6-dicarboxylic acid derivatives, their use, and pharmaceutical composition
US20140206667A1 (en)2012-11-142014-07-24Michela GallagherMethods and compositions for treating schizophrenia
JO3368B1 (en)2013-06-042019-03-13Janssen Pharmaceutica Nv 6, 7- dihydropyrazolu [5,1-a] pyrazine-4 (5 hands) -on compounds and their use as negative excretory regulators of Miglore 2 receptors.
JO3367B1 (en)2013-09-062019-03-13Janssen Pharmaceutica Nv1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
LT3431106T (en)2014-01-212021-02-10Janssen Pharmaceutica NvCombinations comprising positive allosteric modulators of metabotropic glutamatergic receptor subtype 2 and their use
AU2015208233B2 (en)2014-01-212019-08-29Janssen Pharmaceutica NvCombinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5955459A (en)*1997-11-261999-09-21Neuromedica, Inc.Fatty acid-antipsychotic compositions and uses thereof

Also Published As

Publication numberPublication date
EP1492595A1 (en)2005-01-05
CA2478227A1 (en)2003-10-16
JP2005528378A (en)2005-09-22
WO2003084610A1 (en)2003-10-16

Similar Documents

PublicationPublication DateTitle
AU2003218063A1 (en)Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
AU2003290700A1 (en)Farnesoid x receptor agonists
AU2003243637A1 (en)Cannabinoid receptor agonists
AU2003261392A1 (en)M3muscarinic acetylcholine receptor antagonists
AU2003244802A1 (en)Videoconferencing apparatus
EP1499306A4 (en)Bicyclic amides
AU2003302799A1 (en)Video quality measurement
AU2003218005A1 (en)Substituted amides active at the cannabinoid-1 receptor
AU2003259295A1 (en)Self-contained hinge for flip-style device
AU2003231240A1 (en)Portable corral apparatus
AU2003241836A1 (en)Lpa receptor antagonists
AU2002361742A1 (en)Parental analgesic formulations comprising fentanyl and a cannabinoid receptor agonist
AU2003242273A1 (en)Screw supplying device
AU2003255501A1 (en)Cxcr4 receptor antagonists
AU2003249722A1 (en)Therapeutic amides
AU2003301216A1 (en)Novel use of liver x receptor agonists
AU2003267088A1 (en)Chemokine receptor antagonists as therapeutic agents
AU2003286251A1 (en)New bicyclic angiotensin ii agonists
EP1363046A3 (en)Ball screw apparatus
AU2003248356A1 (en)Beta3-adrenergic receptor agonists
EP1420263A3 (en)Voltage standard apparatus
AU2003277552A1 (en)Receptor regulator
AU2003300904A1 (en)Antagonists for human prolactin
AU2003240705A1 (en)Morpholinylmethylureas ccr-3 receptor antagonists
AU2003251627A1 (en)Carvedilol hydrobromide

Legal Events

DateCodeTitleDescription
MK6Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase

[8]ページ先頭

©2009-2025 Movatter.jp